COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature
Main drug interactions were found with tocilizumab, ruxolitinib, and colchicine. Future clinical trials are needed to better understand interactions between different drugs in the context of the COVID-19 pandemic.
